S038 Dermatologic Surgery Pearls: Optimizing Safety, Satisfaction, Efficiency
DESCRIPTION
Open admission to eligible categories, no tuition or ticket
This session will recognize opportunities to enhance the overall dermatologic surgery practice by highlighting pearls to improve patient safety and satisfaction. Discussions will also focus on physician safety and tips on optimizing efficiency in the surgical setting.
LEARNING OBJECTIVES
Discuss pearls to optimize patient and physician safety while maximizing efficiency in the dermatologic surgery clinical practice.
Discuss strategies to improve patient experience and satisfaction.
SCHEDULE
9:00 PM
Managing postoperative pain
Frances M Walocko, MD, FAAD
9:16 PM
Optimizing patient satisfaction
Dana Lynn Sachs, MD, FAAD
9:32 PM
Photography/Biopsy site identification
Kishwer S. Nehal, MD, FAAD
9:50 PM
Questions & Answers
10:00 PM
Office design tips
Andrew R Shors, MD, MPH, FAAD
10:16 PM
Technology tools
David R. Carr, MD, FAAD
10:32 PM
Dermatologic surgery pearls
Valencia D. Thomas, MD, FAAD
10:50 PM
Questions & Answers
11:00 PM
Art of Preop Prep
Emily Clara Newsom, MD, FAAD
11:16 PM
Reducing risk of surgical injuries
Rachel Rigo, MD, FAAD
11:32 PM
Ergonomics in your practice
Patrick K. Lee, MD, FAAD
11:50 PM
Questions & Answers
SPEAKERS
David R. Carr, MD, FAAD
Patrick K. Lee, MD, FAAD
Kishwer S. Nehal, MD, FAAD
Emily Clara Newsom, MD, FAAD
Rachel Rigo, MD, FAAD
Dana Lynn Sachs, MD, FAAD
Andrew R Shors, MD, MPH, FAAD
Valencia D. Thomas, MD, FAAD
Frances M Walocko, MD, FAAD
SPEAKER DISCLOSURES
David R. Carr, MD, FAAD
Regeneron – Investigator(No Compensation Received);
Patrick K. Lee, MD, FAAD
No financial relationships exist with ineligible companies.
Kishwer S. Nehal, MD, FAAD
No financial relationships exist with ineligible companies.
Emily Clara Newsom, MD, FAAD
No financial relationships exist with ineligible companies.
Rachel Rigo, MD, FAAD
No financial relationships exist with ineligible companies.
Dana Lynn Sachs, MD, FAAD
No financial relationships exist with ineligible companies.
Andrew R Shors, MD, MPH, FAAD
No financial relationships exist with ineligible companies.
Valencia D. Thomas, MD, FAAD
Castle Biosciences, Inc – Advisory Board(Honoraria); Merk – Advisory Board(Honoraria); National Comprehensive Cancer Network – Speaker(Honoraria); Sanofi/Regeneron – Advisory Board(Honoraria);
Frances M Walocko, MD, FAAD
No financial relationships exist with ineligible companies.